There is a new type of hyaluronic acid (HA) facial filler on the market called RHA®, a collaboration between the U.S. company Revance and the Swiss manufacturer Teoxane. MARICE COHN BAND MIAMI HERALD ...
"The development of the Teoxane RHA ® Collection with Mepivacaine exemplifies Teoxane's commitment to innovation," states Valérie Taupin, Founder and CEO of Teoxane. "Mepivacaine represents the first ...
We’re back again at AUSTEX Wellness & Medical Spa in Lakeway! We spoke with Laurel Belfiore, Founder & Owner, about dermal fillers which are a great anti-aging tool, but a lot of people are hesitant ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today ...
- Revance gains access to the growing $1.1B U.S. filler market with three differentiated products, and plans to launch in second quarter 2020 - - Fast-tracks Revance’s commercial organization, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results